Clinical variables | N | circFNDC3B | P | FNDC3B mRNA | P | ||
---|---|---|---|---|---|---|---|
Low | High | Low | High | ||||
Gender | |||||||
 Male | 28 | 13 | 15 |  | 15 | 13 |  |
 Female | 22 | 12 | 10 | 0.388 | 10 | 12 | 0.388 |
Age | |||||||
 < 25y | 33 | 14 | 19 |  | 17 | 16 |  |
 ≥ 25y | 17 | 11 | 6 | 0.116 | 8 | 9 | 0.500 |
Tumor size | |||||||
 < 6 cm | 29 | 10 | 19 |  | 22 | 7 |  |
 ≥ 6 cm | 21 | 15 | 6 | 0.010 | 3 | 18 | 0.000 |
Lymph node metastasis | |||||||
 No | 34 | 13 | 21 |  | 20 | 14 |  |
 Yes | 16 | 12 | 4 | 0.016 | 5 | 11 | 0.064 |
Enneking stage | |||||||
 I + IIA | 35 | 14 | 21 |  | 20 | 15 |  |
 IB + III | 15 | 11 | 4 | 0.031 | 5 | 10 | 0.108 |
Differentiation | |||||||
 Well/moderately | 31 | 15 | 16 |  | 16 | 15 |  |
 Poorly/undifferentiated | 19 | 10 | 9 | 0.500 | 9 | 10 | 0.500 |
Location | |||||||
 Femur/tibia | 34 | 17 | 17 |  | 16 | 18 |  |
 Elsewhere | 16 | 8 | 8 | 0.619 | 9 | 7 | 0.381 |